• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hyperbaric oxygen therapy (HBOT )can improve the effectiveness of adalimumab in hidradenitis suppurativa.

作者信息

Marasca Claudio, Vivona Giovanni, Annunziata Maria Carmela, Cacciapuoti Sara, Capasso Emilia, Ciotola Alessandra, Russo Gianmarco, Fabbrocini Gabriella

机构信息

Section of Dermatology, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy -

Section of Anesthesiology and Intensive Care, Department of Nephrology, Urology, General Surgery, Kidney Transplant Surgery, Anesthesiology and Intensive Care, Federico II University, Naples, Italy.

出版信息

G Ital Dermatol Venereol. 2020 Apr;155(2):234-235. doi: 10.23736/S0392-0488.18.05913-8. Epub 2018 Apr 19.

DOI:10.23736/S0392-0488.18.05913-8
PMID:29683280
Abstract
摘要

相似文献

1
Hyperbaric oxygen therapy (HBOT )can improve the effectiveness of adalimumab in hidradenitis suppurativa.高压氧疗法（HBOT）可提高阿达木单抗治疗化脓性汗腺炎的疗效。
G Ital Dermatol Venereol. 2020 Apr;155(2):234-235. doi: 10.23736/S0392-0488.18.05913-8. Epub 2018 Apr 19.
2
The use of hyperbaric oxygen therapy in the treatment of necrotizing soft tissue infections, compromised grafts and flaps, hidradenitis suppurativa, and pyoderma gangrenosum.高压氧疗法在治疗坏死性软组织感染、移植组织和皮瓣失功、化脓性汗腺炎及坏疽性脓皮病中的应用。
Acta Dermatovenerol Alp Pannonica Adriat. 2019 Jun;28(2):81-84.
3
Combination hyperbaric oxygen therapy and ustekinumab for severe hidradenitis suppurativa.联合高压氧疗法与优特克单抗治疗重度化脓性汗腺炎
Pediatr Dermatol. 2019 May;36(3):381-383. doi: 10.1111/pde.13775. Epub 2019 Feb 25.
4
Interventions for Hidradenitis Suppurativa: Updated Summary of an Original Cochrane Review.治疗化脓性汗腺炎的干预措施：一项 Cochrane 原始综述的更新总结。
JAMA Dermatol. 2017 May 1;153(5):458-459. doi: 10.1001/jamadermatol.2017.0432.
5
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?阿达木单抗治疗克罗恩病期间出现化脓性汗腺炎：自相矛盾？
Acta Dermatovenerol Alp Pannonica Adriat. 2017 Mar;26(1):21-23. doi: 10.15570/actaapa.2017.6.
6
Uncommon pretibial bilateral manifestation of Hidradenitis suppurativa (Hurley III) after discontinuation of systemic treatment with adalimumab: a serious reason to prefer surgery as a primary approach?停用阿达木单抗全身治疗后化脓性汗腺炎罕见的双侧胫前表现（Hurley III型）：这是更倾向于将手术作为主要治疗方法的一个重要原因吗？
J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e449-e451. doi: 10.1111/jdv.15773. Epub 2019 Jul 16.
7
Hyperbaric oxygen therapy as an adjunct to surgical treatment of extensive hidradenitis suppurativa.高压氧疗法作为广泛化脓性汗腺炎手术治疗的辅助手段。
World J Surg. 2010 Apr;34(4):861-2; author reply 863. doi: 10.1007/s00268-009-0326-6.
8
Low-dose adalimumab biosimilar (ZRC-3197) in the treatment of hidradenitis suppurativa.低剂量阿达木单抗生物类似药（ZRC-3197）治疗化脓性汗腺炎
Indian J Dermatol Venereol Leprol. 2018 Nov-Dec;84(6):745-747. doi: 10.4103/ijdvl.IJDVL_232_18.
9
A prospective randomized controlled trial assessing the efficacy of adjunctive hyperbaric oxygen therapy in the treatment of hidradenitis suppurativa.一项评估辅助高压氧疗法治疗化脓性汗腺炎疗效的前瞻性随机对照试验。
Int J Dermatol. 2016 Feb;55(2):232-7. doi: 10.1111/ijd.12936. Epub 2015 Aug 12.
10
Severe refractory hidradenitis suppurativa successfully treated with adalimumab in an HIV-positive/hepatitis C virus-positive patient.阿达木单抗成功治疗一名HIV阳性/丙型肝炎病毒阳性患者的重度难治性化脓性汗腺炎
AIDS. 2018 Oct 23;32(16):2436-2438. doi: 10.1097/QAD.0000000000001998.

引用本文的文献

1
Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment.高压氧通过调节肿瘤微环境促进免疫治疗的进展。
Front Oncol. 2023 Sep 15;13:1200619. doi: 10.3389/fonc.2023.1200619. eCollection 2023.
2
Overexpression of hypoxia-inducible factor-1α in hidradenitis suppurativa: the link between deviated immunity and metabolism.在化脓性汗腺炎中缺氧诱导因子-1α 的过表达：偏离的免疫与代谢之间的联系。
Arch Dermatol Res. 2023 Sep;315(7):2107-2118. doi: 10.1007/s00403-023-02594-6. Epub 2023 Mar 24.